Rimegepant bests placebo for preventing migraine

Coronavirus vaccine: Understanding trial results, roll-out and what happens next – an expert guide
21 December 2020
US administers first Moderna vaccines
21 December 2020

Rimegepant bests placebo for preventing migraine

(HealthDay)—Taken every other day, rimegepant demonstrates efficacy for the preventive treatment of migraine, according to a study published online Dec. 15 in The Lancet.

Comments are closed.